| Standards of Input Output Norms (SION) |
Home  Schedules Standards of Input Output Norms (SION) This |
|
|
A. Chemical & Allied Products - Standards of Input Output Norms (SION)
|
|
Showing 3501 to 3688 of 3688 Records |
| |
|
| A3500 |
|
Tabcoat TC Containing Hydroxy Propyl Methyl Cellulose 66% Titanium Dioxide 18.5%
|
|
| A3501 |
|
OT 33 Insoluble Sulphur Containing average 67% elemental sulphur & average oil content 33%
|
|
| A3502 |
|
Catalyst Type : 125-1-01 containing Zinc Oxide 49+/-2%
|
|
| A3503 |
|
Nitro Phenyl Mercapto Aniline
|
|
| A3504 |
|
Ciprofloxacin HCL
|
|
| A3505 |
|
Preservative containing N-Octyl Isothiozolinone (45%) 3.2%-3.4%, Benzimidazole Carbamate 8-10.5% and N (N,N Di-Methyl Amino Carbonyl) 3,4 Dichloro Aniline 20-22%
|
|
| A3506 |
|
Methoxyamine Hydrochloride
|
|
| A3507 |
|
Ethoxy Amine
|
|
| A3508 |
|
Nitrile Butadiene Rubber (with bound acrylonitrile content 33+/-1% & DOP 35% extended)
|
|
| A3509 |
|
Sodium Mercapto-benzothiazole 50% munimum
|
|
| A3510 |
|
Methyl -2-chloro Phenyl acetate (Methyl Orthochloro Phenyl Acetate Or 2- chloro phenyl acetate methyl Ester or Ortho Chloro Phenyl acetate methyl ester)
|
|
| A3511 |
|
2,4 Dichloro Phenyl Acetic Acid
|
|
| A3512 |
|
Disodium Lauryl sulfossuccinate Powder/ Needles/ Granules
|
|
| A3513 |
|
Readymix for manufacturing Transparent combi body wash containing 20% of Sodium Lauryl Ether Sulfate (70%) 8% of coco anmidopropyl betaine (active matter 29%) 18% of Sodium Stearate 10% of Sodium Cocoate 3% free acid each of coconut fatty acid and stearic acid and 24% of Humectants as (Propylene Gly
|
|
| A3514 |
|
Para Xylene Dimethyl Ether
|
|
| A3515 |
|
Deleted, already appears in the entry at S.No. A3487
|
|
| A3516 |
|
Para Chloro Benzyl Cyanide 75% Solution in N-butyl Acetate (4-Chloro Benzyl Cyanide 75% Solution in N-butyl Acetate)
|
|
| A3517 |
|
3,4,4-trichloro Carbanilide
|
|
| A3518 |
|
N-Di Cyclohexyl 2 Benzothiazole Sulphenamide (DCBS)
|
|
| A3519 |
|
Venlafaxine Hcl
|
|
| A3520 |
|
Moxifloxacin Hcl
|
|
| A3521 |
|
Nelfinavir Mesylate
|
|
| A3522 |
|
Clopidogrel Bisulphate
|
|
| A3523 |
|
1-[(2-amino-1(4-Methoxy phenyl) ethyl)] cyclohexanol HCL
|
|
| A3524 |
|
(4R,6R) -6-[2-[(1S,2S, 6R, 8S,8AR)-1,2,6,7,8,8-A-Hexahydro-8-(2,2-dimethyl-1-Oxobutoxy)-2,6-Dimethyl-1-Naphthyl]Ethyl] tetrahydro-4-Hydroxy-Butyloxy-2H-Pyran-2-one
|
|
| A3525 |
|
Nevirapine
|
|
| A3526 |
|
Sertraline HCL
|
|
| A3527 |
|
N-Triphenyl Methyl-2-amino ethanol
|
|
| A3528 |
|
Butyl and EPDM Tubes other than Cycle Tubes containing minimum 13% EPDM Rubber
|
|
| A3529 |
|
Simethicone (Formulation with varying active substance)
|
|
| A3530 |
|
Activated Polydimethyl Siloxane (Simethicone USP)
|
|
| A3531 |
|
Ethylene Oxide
|
|
| A3532 |
|
Potassium Acetate Anhydrous
|
|
| A3533 |
|
Methyl Ethyl Ketone Peroxide 50% w/w min. in Dimethyl Phthalate (Active Oxygen content 9% Min.)
|
|
| A3534 |
|
1,2 Ethandiylbis (oxy ) bis Methanol / 1,6 Dihydroxy Dioxahexane
|
|
| A3535 |
|
Preservative Mixture of Condensate of Ethylene Glycol formaldehyde (46.5-47.5%) and Chloro Methyl Isothiozolinone (0.75%-0.82%)
|
|
| A3536 |
|
Preservative containing 1) 5.3% of 1,2 Benzoisothiazoline-3-one paste (75%) 2) 61% of 1,3,5 Tris (2-Hydroxyethyl)-hexahydrotriazine
|
|
| A3537 |
|
Butyl Methoxy Dibenzoyl Methane
|
|
| A3538 |
|
2-Acrylamido-2-Methyl Propane Sulfonic Acid (purity minimum 99%)
|
|
| A3539 |
|
Glyceryl Mono-oleate
|
|
| A3540 |
|
Fast Red B Base 4 Nitro Ortho Anisidine
|
|
| A3541 |
|
Synthetic Slippers / Sandals with PU Sole of all sorts
|
|
| A3542 |
|
Quinine Bisulphate BP/ USP/EP
|
|
| A3543 |
|
Quinine Base BP/USP/EP
|
|
| A3544 |
|
Glyphosate 41% SL (IPA salt)
|
|
| A3545 |
|
Calcium Carbide
|
|
| A3546 |
|
10- Deacetyl Baccatin - III
|
|
| A3547 |
|
Ortho Cresyl Glycidyl Ether
|
|
| A3548 |
|
Sodium Metaperiodate
|
|
| A3549 |
|
Cheque Security Paper (MICR/Non-MICR)
|
|
| A3550 |
|
Tetrabenzyl Cyclen
|
|
| A3551 |
|
Cyclen
|
|
| A3552 |
|
Ready to assemble office Furniture system/ Modular Furniture/ Storage System/ Computer furniture/ Drawer Unit/Drawer Trolly/ work station/ Student Studio/Filing Cabinet/ Cupboard/ Book Case/ Sliding Door Unit etc.
|
|
| A3553 |
|
Sodium Selenate
|
|
| A3554 |
|
Optical Brightener (C.I.Fluorescent Brightener 220)(assay 25%)
|
|
| A3555 |
|
Paramethoxy Ethyl phenol (4-(2-Methoxy Ethyl) Phenol
|
|
| A3556 |
|
Propiconazole Technical (1-2(2,4-Dichlorophenyl 4 Propyl-1, 3-Dioxolane-2-yl) Methyl)-1H -1,2,4 Triazole) (A.1 88% Min).
|
|
| A3557 |
|
Para Nitro Cumene
|
|
| A3558 |
|
Ethyl Acrylate (Acrylonitrile Route)
|
|
| A3559 |
|
1,3-Butadiene
|
|
| A3560 |
|
Methyl Acrylate (Acrylonitrile Route)
|
|
| A3561 |
|
Titanium dioxide (Rutile)
|
|
| A3562 |
|
Topiramate
|
|
| A3563 |
|
Carvedilol
|
|
| A3564 |
|
Carbamazepine BP/USP
|
|
| A3565 |
|
Benzyl Salicylate
|
|
| A3566 |
|
Eosine (C.I.No. 45380) (Dye content: 90%)
|
|
| A3567 |
|
Copper Sulphate 20% WP (Bordeaux Mixture 20% WP) (Copper Content 20%)
|
|
| A3568 |
|
Fenpropathrin Technical
|
|
| A3569 |
|
Dist. Fatty Acids (C8-C18) Derived from Palm Kernel Oil
|
|
| A3570 |
|
Dist. Fatty Acids (C16-C18) Derived from Palm Stearine
|
|
| A3571 |
|
Optical Brightener Bluton BA LIQ (C.I. Fluorescent Brightener 113) (Assay 20%)
|
|
| A3572 |
|
Optical Brightener C.I Fluorescent Brightener 71 (Assay 97%)
|
|
| A3573 |
|
Montelukast Sodium
|
|
| A3574 |
|
Lauric Mono Ethanol Amide (active content 96% min.)
|
|
| A3575 |
|
Pre-reforming Catalyst containing NiO 46% A1203 33% and Cr.203 1.6%
|
|
| A3576 |
|
Preservative containing Chloromethyl Isothiozolinone content 8.4% (Min) & Methyl Isothiozolinone 2.5% (Min.)
|
|
| A3577 |
|
Beta [(1H-1, 2,4- Triazol-1-yl)methyl]- 2,4-dichloro benzene ethanol (M Alcohol)
|
|
| A3578 |
|
Prinstol/Alurol-MW- 1/Alurol-Prime Base
|
|
| A3579 |
|
Optical Brightener Fluorescent Brightener Bluton UBR Liquid (Assay 22%)
|
|
| A3580 |
|
Optical Brightener Tinopal UP Liquid(C.I. Fluorescent Brightener 113) (Assay 22%)
|
|
| A3581 |
|
Optical Brightening Agent C.I. Fluorescent 251 (Assay 24%)
|
|
| A3582 |
|
Optical Brightening Agent C.I. Fluorescent Brightener 252 (Assay 90%)
|
|
| A3583 |
|
Optical Brightening Agent C.I. Fluorescent Brightener 353 (Assay 54%)
|
|
| A3584 |
|
Optical Brightening Agent C.I. Fluorescent Brightener 90 (Assay 33.5%)
|
|
| A3585 |
|
Optical Brightener Agent C.I. Fluorescent Brightener-252 (Assay 33%)
|
|
| A3586 |
|
Optical Brightener C.I. Fluorescent Brightener 362 (Assay 29.5%)
|
|
| A3587 |
|
Abacavir Sulphate
|
|
| A3588 |
|
Alprazolam
|
|
| A3589 |
|
3,3,5-Trimethyl Cyclohexanol
|
|
| A3589 |
|
3,3,5-Trimethyl Cyclohexanol
|
|
| A3590 |
|
Benzyl Salicylate
|
|
| A3591 |
|
Phenyramidiol Hcl
|
|
| A3592 |
|
Polishing Compound, Rouge AA (containing Synthetic Ferric Oxide Min. 88.2%) and Stearic Acid min. 10%
|
|
| A3593 |
|
Optical Brightening Agent (C.I. Fluorescent Brightener 113) (Assay 32%)
|
|
| A3594 |
|
Fluorescent Flushed Ink Concentrate General Green (Amino Sulphonamide content 47%)
|
|
| A3595 |
|
Fluorescent Flushed Ink Concentrate Saturn Yellow (Amino Sulphonamide content 47%)
|
|
| A3596 |
|
Fluorescent Pigment Red Orange (Amino Sulphonamide Matrix content 95%)
|
|
| A3597 |
|
Fluorescent Ink Concentrate BLUE IV - Invisible Euroblue (Amino Sulphonamide Based matrix content 48%)
|
|
| A3598 |
|
deleted
|
|
| A3599 |
|
5% Palladium on carbon Catalyst
|
|
| A3600 |
|
Fluorescent Pigment Yellow HTPA (Polyester Matrix content 95%)
|
|
| A3601 |
|
Fluorescent Pigment Red HTPA (Polyester Matrix content 95%)
|
|
| A3602 |
|
Fluorescent Pigment Magenta HTPA (Polyester Matrix content 95%)
|
|
| A3603 |
|
Fluorescent Pigment Violet HTPA (Polyester Matrix content 95%)
|
|
| A3604 |
|
Fluorescent Pigment Royal Blue HTPA (Polyester Matrix content 95%)
|
|
| A3605 |
|
Para Floro Aniline
|
|
| A3606 |
|
Clorsulon (4-Amino-6(trichlorovinyl)-m-benzendisulfonamide)
|
|
| A3607 |
|
Toldimfos Sodium
|
|
| A3608 |
|
Nitroxynil
|
|
| A3609 |
|
Dextropropoxyphene base
|
|
| A3610 |
|
Palm Fatty Acid Diamine
|
|
| A3611 |
|
Optical Whitening Agent Optical Brightner CF 200% (Assay 33.5%) C.I. No. Fluorescent Brighter 090
|
|
| A3612 |
|
Potassium Iodide 100% basis
|
|
| A3613 |
|
Cupric Chloride Dihydrate
|
|
| A3614 |
|
Mono Methyl Aniline
|
|
| A3615 |
|
Zinc Salt of 2 Mercapto Benzothiazole (Active Content 93%)
|
|
| A3616 |
|
Mono Methyl Amine Hydrochloride
|
|
| A3617 |
|
Dimethyl Urea
|
|
| A3618 |
|
Alpha Naphthol
|
|
| A3619 |
|
Optical Brightener AMP Liquid (Assay 27%)
|
|
| A3620 |
|
Optical Brightener/Optical Whitening Agent (Fluorescent Brightener 208) (Assay 72%)
|
|
| A3621 |
|
4-Methoxy Phenyl Acetone
|
|
| A3622 |
|
Mirtazapine (From 1-Methyl 3 phenyl piperazine route
|
|
| A3623 |
|
2-Bromopyridine
|
|
| A3624 |
|
2,6 Dichloropyridine
|
|
| A3625 |
|
Lube Oil Base Stock - 500 N ( LOBS)
|
|
| A3626 |
|
3a 7b Dihydroxy
|
|
| A3627 |
|
Glass Vials / Phials / Ampoules / Perfume Bottles / Nail Enamel Bottles /Foundation Bottles/ Miniatures / Cream Jars (Glass Scrap/Cullet route)
|
|
| A3628 |
|
Buff Colour Titanium Dioxide
|
|
| A3629 |
|
Dichloro Diphenyl Trichloro-ethane 75% WP(DDT 75% WP)
|
|
| A3630 |
|
Isatoic Anhydride (N-carboxy Anthranilic Anhydride)
|
|
| A3631 |
|
Butyl Titanate Polymer
|
|
| A3632 |
|
Quinine Hydrochloride BP/USP/EP
|
|
| A3633 |
|
Ethylene Glycol Mono Ethyl Ether Acetate
|
|
| A3634 |
|
Diethylene Glycol Mono Ethyl Ether
|
|
| A3635 |
|
Diethylene Glycol Mono Ethyl Ether Acetate
|
|
| A3636 |
|
Reinforced steel wire Braided Rubber Hose fitted with Non-Alloy Steel Flanges/Couplings
|
|
| A3637 |
|
Timing Belts
|
|
| A3638 |
|
Sawn Timber made exclusively out of imported logs/timber of all the species of wood (other than those specified in Note 1 below)
|
|
| A3639 |
|
Propylene
|
|
| A3639 |
|
Propylene
|
|
| A3640 |
|
Verdyl Acetate
|
|
| A3640 |
|
Verdyl Acetate
|
|
| A3641 |
|
Verdyl Propionate
|
|
| A3641 |
|
Verdyl Propionate
|
|
| A3642 |
|
Amyl Salicylate
|
|
| A3642 |
|
Amyl Salicylate
|
|
| A3643 |
|
Fatty Alcohol (Cetyl, Stearyl, Ceto-Stearyl)
|
|
| A3644 |
|
Sodium Lauryl Ether Sulphate (Active Matter 69% min.)
|
|
| A3645 |
|
Alendronate Sodium Tablets 70 mg (Each Tablet contains Alendronate Sodium equivalent to 70 mg Alendronic acid)
|
|
| A3646 |
|
Amikacin Sulphate Injection 500 mg/2ml (Each 2 ml vial contains Amikacin Sulphate equivalent to Amikacin 500 mg}
|
|
| A3647 |
|
Amoxicillin and Potassium Clavunate 1000 mg Tablets (Each tablet contains Amoxicillin Trihydrate equivalent to Amoxicillin 875 mg and Potassium Clavulanate equivalent to Clavulanic acid 125 mg)
|
|
| A3648 |
|
Amoxicillin & Clavulanic Acid suspension 228.5 mg/5 ml in 100 ml bottles. (Each 5 ml contains Amoxicillin Trihydrate equivalent to Amoxicillin 200 mg and Potassium Clavulanate equivalent to Clavulanic acid 28.5 mg}
|
|
| A3649 |
|
Ampicillin and Sulbactam 750 mg for injection (each vial contains Ampicillin Sodium equivalent to Ampicillin 500 mg and Sulbactam Sodium equivalent to Salbactam 250 mg}
|
|
| A3650 |
|
Ampicillin injection 500 mg (each vial contains Ampicillin Sodium equivalent to Ampicillin 500 mg)
|
|
| A3651 |
|
Atorvastatin Tablets 10 mg(each tablet contains Atorvastatin Calcium Trihydrate equivalent to 10 mg Atorvastatin)
|
|
| A3652 |
|
Benzylpenicillin Injection 5 Lac units (300 mg) {each vial contains Benzylpencillin Sodium equivalent to Benzylpencillin 300 mg}
|
|
| A3653 |
|
Cefadroxil (250 mg) and Potassium Clavulanate (62.5 mg) Dispersible Tablets {each tablet contains cefadroxil monohydrate equivalent to 250 mg Cefadroxil on Anhydrous basis and Clavulanate potassium equivalent to Clavulanic acid 62.5 mg}
|
|
| A3654 |
|
Cefixime for oral suspension 30 ml bottle (each 5 ml contains Cefixime Trihydrate equivalent to Cefixime 50 mg on anhydrous basis}
|
|
| A3655 |
|
Cefixime Tablets 200 mg (each tablet contains Cefixime Tridhydrate equivalent to Cefixime 200 mg on anhydrous basis)
|
|
| A3656 |
|
Cefpodoxime Proxetil Tablets 200 mg (each tablet contains Cefpodoxime Proxetil equivalent to Cefpodoxime 200 mg)
|
|
| A3657 |
|
Ceftriaxone and Sulbactam for injection. 1.5 gm (each vial containing Ceftriaxone Sodium equivalent to Ceftriaxone 1 gm and Salbactam Sodium equivalent to Salbactam 0.50 gm)
|
|
| A3658 |
|
Cefuroxime Axetil Tablets 500 mg (each tablet contains Cefuroxime Axetil equivalent to Cefuroxime 500 mg)
|
|
| A3659 |
|
Cefuroxime for injection 750 mg (Each vial contains Cefuroxime Sodium equivalent to Cefuroxime 750 mg)
|
|
| A3660 |
|
Cefuroxime for oral suspension 125 mg/ 5 ml in 60 ml bottles {each 5 ml containing Cefuroxime Axetil equivalent to Cefuroxime 125 mg)
|
|
| A3661 |
|
Citicoline Injection 250 mg /ml (each vial contains Citicoline Sodium equivalent to Citicoline 250 mg)
|
|
| A3662 |
|
Citicoline Capsules 500 mg (each capsule contains citicoline sodium equivalent to Citicoline 500 mg)
|
|
| A3663 |
|
Clopidogrel Tablets 75 mg (each tablet contains Clopidogrel Bisulphate equivalent to Clopidogrel 75 mg)
|
|
| A3664 |
|
Phenoxy Methyl Penicillin Potassium for oral suspension 250 mg/ 5 ml in 100 ml bottles (each 5 ml contains Phenoxy Methyl Penicillin Potassium equivalent to phenoxy methyl Penicillin 250 mg)
|
|
| A3665 |
|
Erythromycin Stearate for oral suspension 250 mg/5ml in 100 ml bottles {each 5 ml contains Etrythromycin Stearate equivalent to Erythromycin 250 mg)
|
|
| A3666 |
|
Levofloxacin Tablets 500 mg (each tablet contains Levofloxacin Hemihydrate equivalent to Levofloxacin 500 mg on anhydrous basis )
|
|
| A3667 |
|
Meropenem for injection 1 gm ( each vial contains MeropenemTrihydrate equivalent to Meropenem Anhydrous 1 gm)
|
|
| A3668 |
|
Methyl Prednisolone Sodium Succinate for injection 500 mg {each vial containing Methyl Prednisolone Sodium Succinate equivalent to Methyl Prednisolone 500 mg}
|
|
| A3669 |
|
Metronidazole oral suspension 200 mg/5 ml, in 100 ml bottles(each 5 ml suspension contains Metronidazole Benzoate equivalent to 200 mg Metronidazole)
|
|
| A3670 |
|
Pefloxacin Tablet 400 mg (each tablet contains Pefloxacin Mesylate equivalent to Pefloxacin 400 mg)
|
|
| A3671 |
|
Phenoxymethyl Penicillin Potassium tablets 500 mg. {each tablet contains Phenoxymethyl Penicillin Potassium equivalent to Phenoxymethyl Penicillin 500 mg)
|
|
| A3672 |
|
Piperacillin and Tazobactam for injection 2.25 gm (each vial contains Piperacillin Sodium equivalent to Piperacillin 2 gms + Tazobactam Sodium equivalent to Tazobactam 0.25 gm)
|
|
| A3673 |
|
Primaquine Phosphate Tablets 2.5 mg (each tablet contains Primaquine Phophate equivalent to Primaquine 2.5 mg)
|
|
| A3674 |
|
Rosuvastatin 10 mg Tablets (each tablet contains Rosuvastatin Calcium equivalent to Rosuvastatin 10 mg)
|
|
| A3675 |
|
Spectinomycin injection 2 gm/vial (each vial contains Spectinomycin Hydrochloride equivalent to Spectinomycin 2 gm)
|
|
| A3676 |
|
Vancomycin Injection 500 mg (each vial contains Vancomycin Hydrochloride equivalent to Vancomycin 500 mg, vial size less than 10ml}
|
|
| A3677 |
|
Amoxicillin & Potassium Clavulanate for injection 1.2 g (each vial contains Amoxicillin Sodium equivalent to Amoxicillin 1000 mg and Potassium Clavulanate equivalent to Clavulanic Acid 200 mg}
|
|
| A3678 |
|
PHENOL
|
|
| A3679 |
|
ACETONE
|
|
| A3680 |
|
Sodium Salicylate
|
|
| A3681 |
|
Methyl Cobalamin JP (Mecobalamin)
|
|
| A3682 |
|
Clobetasol Propionate
|
|
| |
| .... |
| |
| |
9911796707
